ID EBAG_FLAST Reviewed; 314 AA. AC P80036; Q9F1K1; DT 01-NOV-1991, integrated into UniProtKB/Swiss-Prot. DT 15-JAN-2008, sequence version 2. DT 22-FEB-2023, entry version 82. DE RecName: Full=Endo-beta-N-acetylglucosaminidase; DE EC=3.2.1.96; DE AltName: Full=DI-N-acetylchitobiosyl beta-N-acetylglucosaminidase; DE AltName: Full=Endo-Fsp; DE AltName: Full=Mannosyl-glycoprotein endo-beta-N-acetyl-glucosaminidase; DE Flags: Precursor; OS Flavobacterium sp. (strain SK1022). OC Bacteria; Bacteroidota; Flavobacteriia; Flavobacteriales; OC Flavobacteriaceae; Flavobacterium. OX NCBI_TaxID=148444; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, RP BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY, AND MUTAGENESIS OF RP TYR-60; ASP-168; GLY-169; ASP-173; ASP-174; GLU-175 AND TYR-238. RX PubMed=11515537; DOI=10.1271/bbb.65.1542; RA Fujita K., Nakatake R., Yamabe K., Watanabe A., Asada Y., Takegawa K.; RT "Identification of amino acid residues essential for the substrate RT specificity of Flavobacterium sp. endo-beta-N-acetylglucosaminidase."; RL Biosci. Biotechnol. Biochem. 65:1542-1548(2001). RN [2] RP PROTEIN SEQUENCE OF 48-314. RX PubMed=1935974; DOI=10.1111/j.1432-1033.1991.tb16359.x; RA Takegawa K., Mikami B., Iwahara S., Morita Y., Yamamoto K., Tochikura T.; RT "Complete amino acid sequence of endo-beta-N-acetylglucosaminidase from RT Flavobacterium sp."; RL Eur. J. Biochem. 202:175-180(1991). CC -!- FUNCTION: Cleaves asparagine-linked oligomannose and hybrid, but not CC complex, oligosaccharides from glycoproteins. CC {ECO:0000269|PubMed:11515537}. CC -!- CATALYTIC ACTIVITY: CC Reaction=an N(4)-(oligosaccharide-(1->3)-[oligosaccharide-(1->6)]-beta- CC D-Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc)-L-asparaginyl- CC [protein] + H2O = an oligosaccharide-(1->3)-[oligosaccharide-(1->6)]- CC beta-D-Man-(1->4)-D-GlcNAc + N(4)-(N-acetyl-beta-D-glucosaminyl)-L- CC asparaginyl-[protein]; Xref=Rhea:RHEA:73067, Rhea:RHEA-COMP:12603, CC Rhea:RHEA-COMP:18176, ChEBI:CHEBI:15377, ChEBI:CHEBI:132248, CC ChEBI:CHEBI:192714, ChEBI:CHEBI:192715; EC=3.2.1.96; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 5.0-9.0. {ECO:0000269|PubMed:11515537}; CC -!- SUBUNIT: Monomer. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:11515537}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 18 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB053207; BAB20938.1; -; Genomic_DNA. DR PIR; S19538; S19538. DR AlphaFoldDB; P80036; -. DR SMR; P80036; -. DR CAZy; GH18; Glycoside Hydrolase Family 18. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0033925; F:mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity; IEA:UniProtKB-EC. DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro. DR CDD; cd06542; GH18_EndoS-like; 1. DR Gene3D; 3.20.20.80; Glycosidases; 1. DR InterPro; IPR016289; Endo-Fsp. DR InterPro; IPR001223; Glyco_hydro18_cat. DR InterPro; IPR001579; Glyco_hydro_18_chit_AS. DR InterPro; IPR017853; Glycoside_hydrolase_SF. DR Pfam; PF00704; Glyco_hydro_18; 1. DR PIRSF; PIRSF001103; Endo-b-N-acetylglucosaminidase; 1. DR SUPFAM; SSF51445; (Trans)glycosidases; 1. DR PROSITE; PS01095; GH18_1; 1. DR PROSITE; PS51910; GH18_2; 1. PE 1: Evidence at protein level; KW Direct protein sequencing; Glycosidase; Hydrolase; Secreted; Signal. FT SIGNAL 1..47 FT /evidence="ECO:0000269|PubMed:1935974" FT CHAIN 48..314 FT /note="Endo-beta-N-acetylglucosaminidase" FT /id="PRO_0000077053" FT DOMAIN 55..309 FT /note="GH18" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01258" FT REGION 14..54 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 175 FT /note="Proton donor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01258" FT SITE 174 FT /note="Important for substrate specificity" FT MUTAGEN 60 FT /note="Y->A: Reduced catalytic activity." FT /evidence="ECO:0000269|PubMed:11515537" FT MUTAGEN 168 FT /note="D->N: Loss of catalytic activity." FT /evidence="ECO:0000269|PubMed:11515537" FT MUTAGEN 169 FT /note="G->L: Reduced catalytic activity." FT /evidence="ECO:0000269|PubMed:11515537" FT MUTAGEN 173 FT /note="D->E,N: Reduced catalytic activity." FT /evidence="ECO:0000269|PubMed:11515537" FT MUTAGEN 174 FT /note="D->E,N: Reduced catalytic activity toward hybrid FT type oligosaccharides." FT /evidence="ECO:0000269|PubMed:11515537" FT MUTAGEN 175 FT /note="E->A: Loss of catalytic activity." FT /evidence="ECO:0000269|PubMed:11515537" FT MUTAGEN 238 FT /note="Y->A: Reduced catalytic activity." FT /evidence="ECO:0000269|PubMed:11515537" FT CONFLICT 194 FT /note="W -> G (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 314 AA; 32936 MW; 0227CD75BE4DC5BF CRC64; MQFGIVAAIA DGGRTARAGG SVRPPRRPPA SHTAWGLPRG RPTGQPHATP TKSGPTSIAY VEVNNDQLAN VGRYQLANGA NAFDVAIIFA ANINWNGSKA VLYNNENVQA TLDDAATQIR PLQAKGIKVS LSILGNHQGA GIANFPTQAA AEDFAAQVSA TVSKYGLDGV DLDDEYSDYG TNGTPQPNQQ SIGWLISALR ADVPGKLISF YDIGPASSAL SSSSSTIGSK LDYAWNPYYG TYSAPSIPGL DKSRLSAAAV DVQNTPQSTA VSLAQRTKAD GYGVFMTYNL PDGDVSPYVS SMTKVLYGQA ATYH //